Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
J'accuse! @WhollyTerriers of writing a title to a post that none of us can pronounce. I know it was intentional and I think it's funny. I'm glad not to be one of their phone reps.
Agree with @kevindow. I made some dough when the MS fund open-ended in 2012 and for a while thereafter, but sold in 2013. I'm also aggressive, but I don't see frontier markets as a place that will improve my EM or international returns.
Closed out JOHAX after another disappointing year. Adding to FMIJX in foreign large cap allocation. BTW, M* still has OAKIX as gold, 5 star but FMIJX has truly clocked it for three years.
Good explanation, @Crash. I nominate "risible" for word of the year, but you should get the credit for using it. I doubt I have ever received more than the price of a bowl of soup out of the suits filed on my behalf.
On the face of it, QLEIX is a great fund. That minimum investment amount leaves me out in the cold, however. Come to think of it,all I have to do is step out the door today and I'm out in the cold. I suppose an "advisor" could get me into AQR funds…
Got to agree with @hank. Those of us in SFGIX (and GPEOX) are not getting paid much for the risk taken. We could do just as well with a bond fund. EMs had a bit of excitement last year, but how many times in the past were we told "this is the year f…
I can't get my brain 'round the name of the funds, nor can I pronounce it satisfactorily. "Rondeur" would have been in keeping with "Grandeur" and all Americans, save the French-speaking Mormons (like Mitt Romney) would mispronounce them both. Now w…
Now that the WSJ is two sections and because I did not renew Barron's, I have to scramble for paper to light my fireplace. BTW, the WSJ offered me a renewal at $49 for the year.
Quite a while back I had an inflated view of Bridgeway, owning 3 or 4 funds and two IRAs. The micro cap fund had to be absorbed into another, BRUSX really cratered, and BRAGX swooned. No longer own any of these, but have been happy with American Bea…
As kevindow said, there's no reason to sell XMLV. It has slightly underperformed the Russell mid-cap index since the election, but it's no cause for changing horses.
It hit about $7.50 today, way below the $14 it hit when resumption of diplomatic relations was announced in 2014. Any way I look at it, this fund has not made anyone much dough over its lifespan. It remains an "idea" investment for me and believe me…
I wondered if Geritz left Wasatch and subsequently entered into talks with GP as the letter to investors makes it sound. Just didn't ring entirely true to me.
Hard to believe that RPMGX ranks at the top of Lipper's MCG category when AKREX has clocked it since the latter's inception in 2009. AKREX's buy-and-hold strategy will result in me paying around 4 cents per share in distributions. A fund to hold.
Just dropped my long-time subscription (an el-cheapo one at that) because of irrelevance. Got sick of seeing Mario Gabelli and the like year after year.
The NEA has done a terrible job of representing teachers and their investment options beyond what defined benefit programs most states and school districts have offered. Now that many teachers are being forced into defined contribution retirement pl…
LC Core: SFLA and MOAT
LC Growth: ROLA and LSGRX
If you subscribe, the following link will take you to the relevant page:
http://online.wsj.com/mdc/public/page/2_3061-mfq16_3_CategoryKings.html#catcore1
Glad to see MOAT up there as I got back in…
The WSJ monthly rankings of funds has DSENX and CAPE at #1 and #2 for one-year performance in the Large Value category. CAPE still has only about $35M in assets, so come on, momentum guys!
For an allocation fund whose performance has hugged the return of the S&P 500 for the past 10 years, go for the Bruce Fund (BRUFX). It's by far my biggest MF holding.
Thanks for this posting. I found it long and repetitive, but maybe that's the true lesson for a value investor. My other observation is that Klarman implies you have to work constantly at uncovering undervalued securities. Seems to be advice for the…
Higher Ed is way behind in developing and implementing instruments that really measure what students learn during their tenure in college. Sometimes called "assessment," a good system requires the faculty to say in concrete terms what it takes to ea…
Not exactly the same animal, but RIV from RiverNorth has been operating since last December as a CEF of CEFs. Presently it trades at about a 2.7% discount. RIV can hold ETFs, but it does not seem to now. NAV has risen about 6%, but the price only 1%…
I am puzzled by the transaction as well. A Connecticut regional bank is taking over G-F, but the articles I saw say nothing about preserving the management of the MF's. Here's one announcement:
http://www.prnewswire.com/news-releases/peoples-united…
As for SEEDX, it was what I call a good "story" fund. It seemed the managers had great pedigrees and their plan seemed like a winner. There are "story" stocks out there and they are known money pits; I'd venture the same for some new MFs.
THQ is a bit of an odd-ball in Tekla's line-up of four health funds. Goal is more income than capital appreciation. I'm not sure why its discount has been so high, but it has come down. HQH and HQL do not have appreciable discount or premiums these …
@davidmoran: CAPE is not hard to trade if you are willing to pay/accept the bid/offer. If you count your pennies, however, it may be hard to get the price you think is fair. Low volume seems to create the wide spread.
@TSP_Transfer: thanks for posting the recap of the February webcast. The last line of that pdf reads, "DoubleLine believes the Fund would be a compliment to other large-cap value strategies." Whether it's a compliment or a complement, only the gramm…
